期刊文献+

从先天性心脏病肺血管病理学资料看心外科临床发展中的困惑 被引量:2

下载PDF
导出
摘要 先天性心脏病(先心病)的肺血管病变可分为两大类:肺循环多血流、高血压(pulmonary arterial hypertension,PAH)、高阻力性及低血流、低阻力、低压性.前者如室间隔缺损相关APAH,后者如法洛四联症等引起.它们的重度肺血管病变都影响畸形矫正手术的预后.然而临床如何识别肺血管病变的种类及判断其可逆与否,是国内外尚未解决而又重要的课题.我们从两医院的病理资料可看出先心病当前诊疗发展中应深入探讨的问题.
作者 阮英茆
出处 《心肺血管病杂志》 CAS 2014年第2期150-151,共2页 Journal of Cardiovascular and Pulmonary Diseases
  • 相关文献

参考文献8

  • 1Simonneau G,Robbins IM,Beghetti M,et al.Updated clinical classification of pulmonary hypertension.JACC,2009,54:s43-s54.
  • 2Tuder RM,Marecki JC,Richter A,et al.Pathology of pulmonary hypertension.Clin Chest Med,2007,28:23-vii.
  • 3阮英茆,李莉.肺循环疾病病理解剖学//陆慰萱,王晨.肺循环疾病.北京:人民卫生出版社,2007:38-74.
  • 4Jaklitsch MT,Linden BC,Brannlin EA,et al.Open-lung biopsy guides therapy in children.Ann Thorac Surg,2001,71:1779-1785.
  • 5Choe KO,Cho BK,Choi BW,et al.Histologic changes of pulmonary arteries in congenital heart disease with left-to-right shunt (part 1):correlated with preoperative pulmonary hemodynamics.Yonsei Medical Journal,2002,43:73-81.
  • 6Levy M,Maurey C,Celermajer DS,et al.Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease.JACC,2007,49:803-810.
  • 7Smadja DM,Gaussem P,Mauge L,et al.Circulating endothelial cells,a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease.Circulation,2009,119:374-381.
  • 8Yamaki S.Pulmonary vascular disease associated with pulmonary hypertension in 445 patients:diagnosis from lung biopsy and autopsy.Gen Thorac Cardiovasc Surg,2013,61:24-31.

同被引文献24

  • 1GalieN,Rubin LJ,Hoeper M,et al.Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan(EARLY study):a double-blind,randomized controlled trial.Lancet,2008,371:2093-2100.
  • 2Galie N,Beghetti M,Gatzoulis MA,et al.Bosentan therapy in patients with Eisenmenger syndrome:a multicenter,doubleblind,randomized,placebo-controlled study.Circulation,2006,114:48-54.
  • 3GalièN1,Hoeper MM,Humbert M,et al.Guidelines for the diagnosis and treatment of pulmonary hypertension:the task force for the diagnosis and treatment of pulmonary hypertension of the european society of cardiology(ESC)and the european respiratory society(ERS),endorsed by the International society of heart and lung transplantation(ISHLT).Eur Heart J,2009,30:2493-537.
  • 4Corretti MC,Anderson TJ,Benjamin EJ,et al.Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery:a report of the International Brachial Artery Reactivity Task Force.J Am Coll Cardiol,2002,16,39:257-65.
  • 5Therrien J,Rambihar S,Newman B,et al.Eisenmenger syndrome and atrial septal defect:nature or nurture?Can J Cardiol,2006,22:1133-6.
  • 6Strange G,Keogh A,Williams T,et al.Bosentan therapy in patients with pulmonary arterial hypertension:the relationship between improvements in 6 minute walk distance and quality of life.Respirology,2008,13:674-682.
  • 7Chen SJ,Chen YF,Meng QC,et al.Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats.J Appl Physiol,1995,79:2122-2131.
  • 8Sfikakis PP,Papamichael C,Stamatelopoulos KS,et al.Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis.Arthritis Rheum,2007,56:1985-1993.
  • 9蒋瑶.先天性心脏病术后患儿的呼吸道管理[J].护理实践与研究,2011,8(5):58-59. 被引量:3
  • 10任燕,程良平,龚仁蓉.低体质量婴幼儿先天性心脏病伴重度肺动脉高压术后呼吸道管理[J].护理研究(中旬版),2011,25(11):2986-2987. 被引量:2

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部